Simvastatin enhances oxidized‑low density lipoprotein‑induced macrophage autophagy and attenuates lipid aggregation

Huang,Baojun; Jin,Mengxing; Yan,Hai; Cheng,Yanwei; Huang,Dake; Ying,Songcheng; Zhang,Linjie

doi:10.3892/mmr.2014.2790

Simvastatin enhances oxidized‑low density lipoprotein‑induced macrophage autophagy and attenuates lipid aggregation

Authors:
- Baojun Huang
- Mengxing Jin
- Hai Yan
- Yanwei Cheng
- Dake Huang
- Songcheng Ying
- Linjie Zhang
View Affiliations

Affiliations: Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China, Comprehensive Laboratory, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China
Published online on: October 27, 2014 https://doi.org/10.3892/mmr.2014.2790
Pages: 1093-1098

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Macrophage autophagy exerts a protective effect in advanced atherosclerosis. It has previously been reported that oxidized low‑density lipoprotein (ox‑LDL) induces autophagy in endothelial cells, and simvastatin enhances autophagy in coronary arterial myocytes. However, it is currently unknown whether ox‑LDL induces autophagy in macrophages, or whether simvastatin affects macrophage autophagy in atherosclerosis. The present study demonstrated that ox‑LDL induced lipid accumulation in the J774A.1 macrophage cell line, in a dose‑dependent manner, as determined by oil red O staining. Ox‑LDL also induced autophagy in the J774A.1 cells, by converting microtubule‑associated protein 1 light chain 3 (LC3) I to LC3 II, which is a well‑known autophagy marker. Notably, treatment of the cells with simvastatin elevated ox‑LDL‑induced macrophage autophagy, this was detected through the conversion of LC3 I to LC3 II and the increased expression of Beclin1, another autophagy marker. Furthermore, it was shown that stimulation with ox‑LDL led to the redistribution of green fluorescent protein (GFP)‑LC3 from diffusion distribution, to the formation of puncta in the J774A.1 cells. Simvastatin promoted the ox‑LDL‑induced formation of GFP‑LC3 puncta, as detected by confocal laser scanning microscopy. Simvastatin was also shown to inhibit ox‑LDL‑induced cholesterol accumulation in the J774A.1 cells, as observed by oil red O staining and CHOD‑PAP assay. These results suggest that simvastatin may enhance ox‑LDL‑induced macrophage autophagy and attenuate lipid aggregation.

View Figures

View References

1	Legein B, Temmerman L, Biessen EA and Lutgens E: Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci. 70:3847–3869. 2013. View Article : Google Scholar : PubMed/NCBI
2	Cybulsky MI, Won D and Haidari M: Leukocyte recruitment to atherosclerotic lesions. Can J Cardiol. 20:24B–28B. 2004.PubMed/NCBI
3	Moore KJ, Sheedy FJ and Fisher EA: Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 13:709–721. 2013. View Article : Google Scholar : PubMed/NCBI
4	Martinet W and De Meyer GR: Autophagy in atherosclerosis. Curr Atheroscler Rep. 10:216–223. 2008. View Article : Google Scholar : PubMed/NCBI
5	Martinet W and De Meyer GR: Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res. 104:304–317. 2009. View Article : Google Scholar : PubMed/NCBI
6	Schrijvers DM, De Meyer GR and Martinet W: Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler Thromb Vasc Biol. 31:2787–2791. 2011. View Article : Google Scholar : PubMed/NCBI
7	Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J and Tabas I: Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 15:545–553. 2012. View Article : Google Scholar : PubMed/NCBI
8	Zhang YL, Cao YJ, Zhang X, Liu HH, Tong T, Xiao GD, Yang YP and Liu CF: The autophagy-lysosome pathway: a novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells. Biochem Biophys Res Commun. 394:377–382. 2010. View Article : Google Scholar : PubMed/NCBI
9	Muller C, Salvayre R, Nègre-Salvayre A and Vindis C: HDLs inhibit endoplasmic reticulum stress and autophagic response induced by oxidized LDLs. Cell Death Differ. 18:817–828. 2011. View Article : Google Scholar :
10	Almuti K, Rimawi R, Spevack D and Ostfeld RJ: Effects of statins beyond lipid lowering: potential for clinical benefits. Int J Cardiol. 109:7–15. 2006. View Article : Google Scholar
11	Bu DX, Griffin G and Lichtman AH: Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol. 22:165–170. 2011. View Article : Google Scholar : PubMed/NCBI
12	Wierzbicki AS, Poston R and Ferro A: The lipid and non-lipid effects of statins. Pharmacol Ther. 99:95–112. 2003. View Article : Google Scholar : PubMed/NCBI
13	Marzilli M: Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering. Am J Cardiovasc Drugs. 10(Suppl 1): 3–9. 2010. View Article : Google Scholar : PubMed/NCBI
14	Wei YM, Li X, Xu M, Abais JM, Chen Y, Riebling CR, Boini KM, Li PL and Zhang Y: Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem. 31:925–937. 2013. View Article : Google Scholar : PubMed/NCBI
15	Zhang M, Huang BJ, Hu MC, Chen YW, Song W, Huang DK, Li Q and Hu CS: Lipopolysaccharide induces formation of autophagy-related LC3B-GFP fluorescent aggregates in the RAW264.7 macropahge cells. J Anhui Medical Uni. 47:357–361. 2012.(In Chinese).
16	Nowicki M, Zabirnyk O, Duerrschmidt N, Borlak J and Spanel-Borowski K: No upregulation of lectin-like oxidized low-density lipoprotein receptor-1 in serum-deprived EA.hy926 endothelial cells under oxLDL exposure, but increase in autophagy. Eur J Cell Biol. 86:605–616. 2007. View Article : Google Scholar : PubMed/NCBI
17	Lai EH, Hong CY, Kok SH, Hou KL, Chao LH, Lin LD, Chen MH, Wu PH and Lin SK: Simvastatin alleviates the progression of periapical lesions by modulating autophagy and apoptosis in osteoblasts. J Endod. 38:757–763. 2012. View Article : Google Scholar : PubMed/NCBI
18	Maiolino G, Rossitto G, Caielli P, Bisogni V, Rossi GP and Calò LA: The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm. 2013:7146532013. View Article : Google Scholar : PubMed/NCBI
19	Mitra S, Goyal T and Mehta JL: Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther. 25:419–429. 2011. View Article : Google Scholar : PubMed/NCBI
20	Ding Z, Wang X, Khaidakov M, Liu S, Dai Y and Mehta JL: Degradation of heparan sulfate proteoglycans enhances oxidized-LDL-mediated autophagy and apoptosis in human endothelial cells. Biochem Biophys Res Commun. 426:106–111. 2012. View Article : Google Scholar : PubMed/NCBI
21	Ouimet M and Marcel YL: Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol. 32:575–581. 2012. View Article : Google Scholar
22	Martinet W, De Meyer I, Verheye S, Schrijvers DM, Timmermans JP and De Meyer GR: Drug-induced macrophage autophagy in atherosclerosis: for better or worse? Basic Res Cardiol. 108:3212013. View Article : Google Scholar